Merit Medical Systems Inc (MMSI) is a publicly traded Healthcare sector company. As of May 21, 2026, MMSI trades at $64.46 with a market cap of $3.80B and a P/E ratio of 29.58. MMSI moved +1.13% today. Year to date, MMSI is -27.88%; over the trailing twelve months it is -34.73%. Its 52-week range spans $59.74 to $111.45. Analyst consensus is strong buy with an average price target of $87.50. Rallies surfaces MMSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Merit Medical Q1 Net Income Hits $56.7M, Viewpoint Deal Triples Oncology Market: Merit Medical reported Q1 net income of $56.7 million, or $0.94 per share, up from $52.9 million, while losing $1.5 million in sales due to shipping disruptions. The Viewpoint Medical acquisition, dilutive by $0.05, is projected to triple its oncology procedure market and boost its Resilience esophageal stent platform.
| Metric | Value |
|---|---|
| Price | $64.46 |
| Market Cap | $3.80B |
| P/E Ratio | 29.58 |
| EPS | $2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $111.45 |
| 52-Week Low | $59.74 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.52B |
| Net Income | $128.49M |
| Gross Margin | 48.70% |
10 analysts cover MMSI: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $87.50.